$FORM Cashflow Statement | Understand Stock

$FORM

$101.11 +$2.60 (2.64%) Close

$FORM Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 27, 2025	FY2024 12 months to Dec 28, 2024	FY2023 12 months to Dec 30, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 25, 2021
Cash flows from operating activities:
Net income
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
Amortization
Accretion of discount on investments
Reduction in the carrying amount of right-of-use assets
Stock-based compensation expense
Amortization of debt issuance costs
Deferred income tax provision (benefit)
Gain on sale of business
Provision for excess and obsolete inventories
Acquired inventory step-up amortization
Loss on disposal of long-lived assets
Non-cash restructuring charges
Gain on contingent consideration
Foreign currency transaction losses
Loss on derivative instruments
Other than temporary impairment on debt receivable
Changes in assets and liabilities:
Accounts receivable
Inventories
Prepaid expenses and other current assets
Other assets
Accounts payable
Accrued liabilities
Other liabilities
Deferred revenues
Deferred grant
Operating lease liabilities

Net cash provided by operating activities
Cash flows from investing activities:
Acquisition of property, plant and equipment
Acquisition of business, net of cash acquired
Proceeds from sale of business and assets
Purchase of promissory note receivable
Purchases of marketable securities
Proceeds from maturities and sales of marketable securities
Net cash provided by (used in) investing activities
Cash flows from financing activities:
Proceeds from issuances of common stock
Purchase of common stock through stock repurchase program, including excise tax paid
Tax withholdings related to net share settlements of equity awards
Proceeds from term loan
Payments on term loan
Payment of term loan issuance costs
Payment of contingent consideration
Net cash used in financing activities

Effect of exchange rate changes on cash, cash equivalents and restricted cash
Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash, beginning of year
Cash, cash equivalents and restricted cash, end of year
Income (Loss) from Equity Method Investments
Payments to Acquire Equity Method Investments
Supplemental disclosure of non-cash investing and financing activities:
Contingent consideration payable related to FRT acquisition
Operating lease, right-of-use assets obtained in exchange for lease obligations
Increase (decrease) in accounts payable and accrued liabilities related to property, plant and equipment purchases

Supplemental disclosure of cash flow information:
Cash paid for income taxes, net
Cash paid for interest
Operating cash outflows from operating leases
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents
Restricted cash, current
Restricted cash

Comments